Methoxamine
Methoxamine is an α1-adrenergic receptor agonist,[1] somewhat similar in structure to butaxamine and 2,5-DMA. It is no longer marketed.
Not to be confused with methoxetamine.
Clinical data | |
---|---|
Trade names | Vasoxyl |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 3 hours |
Excretion | renal |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.006.244 |
Chemical and physical data | |
Formula | C11H17NO3 |
Molar mass | 211.258 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
References
- Pazdernik TL, Kerecsen L (2007) [2003]. "5". In Goljan EF (ed.). Pharmacology. Rapid Review (Second ed.). Philadelphia, PA: Mosby-Elsevier. p. 39. ISBN 978-0-323-04550-6.
Cardiac stimulants excluding cardiac glycosides (C01C) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adrenergic and dopaminergic agents |
| ||||||||||||||
Phosphodiesterase inhibitors (PDE3I) | |||||||||||||||
Other cardiac stimulants | |||||||||||||||
|
Decongestants and other nasal preparations (R01) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Topical |
| ||||||||||
Systemic use: Sympathomimetics | |||||||||||
|
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.